We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA WARNING WON'T AFFECT CAROTID STENT PMA, CORDIS SAYS
FDA WARNING WON'T AFFECT CAROTID STENT PMA, CORDIS SAYS
July 23, 2004
Cordis recently found itself on the receiving end of an FDA warning letter for sponsor deficiencies discovered in a clinical trial of its Precise carotid stent, but company officials said they don’t expect the action to affect Precise’s pending premarket approval (PMA) application.